Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.26 is 55% above its 5-year average of -0.58, near the high end of its 5-year range (-0.79–-0.22).
40.43% above its 12-month average of -0.44.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-07-31): -0.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.26
EARNINGS PER SHARE (EPS) AVG TTM
-0.44
EARNINGS PER SHARE (EPS) AVG 3Y
-0.60
EARNINGS PER SHARE (EPS) AVG 5Y
-0.58
EARNINGS PER SHARE (EPS) AVG 10Y
-0.50
EARNINGS PER SHARE (EPS) AVG 15Y
-0.41
EARNINGS PER SHARE (EPS) AVG 20Y
-0.54
CURRENT VS TTM AVG
+40.43%
CURRENT VS 3Y AVG
+56.84%
CURRENT VS 5Y AVG
+54.81%
CURRENT VS 10Y AVG
+48.25%
CURRENT VS 15Y AVG
+36.98%
CURRENT VS 20Y AVG
+51.41%
MindWalk Holdings Corp.
Market Cap
$70.48M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.44
3Y Avg
-0.60
5Y Avg
-0.58
Market Cap
$68.60M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$72.94M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.75
3Y Avg
-1.17
5Y Avg
-1.06
Market Cap
$67.84M
Earnings Per Share (EPS)
-0.33
TTM Avg
-1.03
3Y Avg
-28.69
5Y Avg
-510.63
Market Cap
$67.38M
Earnings Per Share (EPS)
-0.08
TTM Avg
0.13
3Y Avg
-0.17
5Y Avg
-0.10
Market Cap
$66.30M
Earnings Per Share (EPS)
-0.32
TTM Avg
-0.34
3Y Avg
-0.43
5Y Avg
-0.40
Market Cap
$65.46M
Earnings Per Share (EPS)
-5.01
TTM Avg
-7.16
3Y Avg
-89.38
5Y Avg
-71.00
Market Cap
$75.84M
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.49
3Y Avg
-0.66
5Y Avg
-0.75
Market Cap
$64.96M
Earnings Per Share (EPS)
-55.66
TTM Avg
-39.81
3Y Avg
-97.72
5Y Avg
-154.19
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MindWalk Holdings Corp. (HYFT) | $70.48M | -0.26 | -0.44 | -0.60 | -0.58 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 2.68 | -1.38 | -6.44 | -7.90 |
| Gain Therapeutics, Inc. (GANX)vs › | $72.94M | -0.50 | -0.75 | -1.17 | -1.06 |
| iBio, Inc. (IBIO)vs › | $67.84M | -0.33 | -1.03 | -28.69 | -510.63 |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | -0.08 | 0.13 | -0.17 | -0.10 |
| RenovoRx, Inc. (RNXT)vs › | $66.30M | -0.32 | -0.34 | -0.43 | -0.40 |
| Cingulate Inc. (CING)vs › | $65.46M | -5.01 | -7.16 | -89.38 | -71.00 |
| Hyperfine, Inc. (HYPR)vs › | $75.84M | -0.38 | -0.49 | -0.66 | -0.75 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.96M | -55.66 | -39.81 | -97.72 | -154.19 |
| Outset Medical, Inc. (OM)vs › | $76.10M | -4.09 | -21.16 | -36.34 | -37.75 |
Trailing EPS (TTM)
$-0.26
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-04-30 | -0.22 |
| 2025-04-30 | -0.65 |
| 2024-04-30 | -0.75 |
| 2023-04-30 | -0.79 |
| 2022-04-30 | -0.68 |
| 2021-04-30 | -0.37 |
| 2020-04-30 | -0.26 |
| 2019-04-30 | -0.46 |
| 2018-04-30 | -0.44 |
| 2017-04-30 | -1.00 |
| 2016-04-30 | 0.08 |
| 2014-12-31 | -0.09 |
| 2013-12-31 | 0.10 |
| 2012-12-31 | -0.18 |
| 2011-12-31 | -0.49 |
| 2010-12-31 | -9.59 |
| 2009-12-31 | -1.71 |
| 2008-12-31 | -0.82 |
| 2007-12-31 | -1.81 |
| 2006-12-31 | -0.92 |
| 2005-12-31 | -0.96 |
| 2004-12-31 | -0.50 |
| 2003-12-31 | -1.85 |
| 2002-12-31 | -0.82 |
| 2001-12-31 | -0.83 |
| 2000-12-31 | -0.59 |
| 1999-12-31 | -5.64 |
| 1998-12-31 | -5.36 |
| 1997-12-31 | -3.52 |
| 1996-12-31 | -3.46 |
